Credits: None available.
Health care insurance is now available to everyone through the Affordable Care Act. How does that impact health policy and care for chronic kidney disease and end-stage renal disease? Is it the same for all individuals? Policy expert Kathleen Smith will share some intriguing insights.
Contact hours available until 10/10/18.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:Conferences Committee Disclosures:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Nephrology nurses are able to discuss health policy, the impact of insurance (and lack thereof) on dialysis patients, and the potential future implications to ESRD patients.
You must be logged in and own this session in order to post comments.
Excellent review of ESRD Coverage under Medicare & ACA. I have been a dialysis Nurse since 1976 and know how the changes have effected the dialysis patients and staff.
Review of ESRD coverage
great in-service .. i really want know more about insurance
Very interesting and helped me understand the challenges that ESRD patients have to deal with regarding payment of dialysis treatment.
I HAVE SO MUCH CONFUSIONS ABOUT MEDICARE AND MEDICAID INSURANCE. I WANT TO HEAR ABOUT IT MORE AND MORE IN FUTURE. ALSO WILL READ THIS AGAIN AND AGAIN
ESRD coverage is supported by Medicare and ACA, but gaps can cause problems for non citizens and Medicare beneficiaries under age 65 who need medical.
Very informative and enjoyed the question/discussion after.
apprecicate the time put into this presentation Some new information for me would like to know more about AKI and IP care of CKD population re-imbursements